NO300128B1 - Fremgangsmåte for fremstilling av polyaminer i edderkoppgift - Google Patents

Fremgangsmåte for fremstilling av polyaminer i edderkoppgift Download PDF

Info

Publication number
NO300128B1
NO300128B1 NO901881A NO901881A NO300128B1 NO 300128 B1 NO300128 B1 NO 300128B1 NO 901881 A NO901881 A NO 901881A NO 901881 A NO901881 A NO 901881A NO 300128 B1 NO300128 B1 NO 300128B1
Authority
NO
Norway
Prior art keywords
compound
formula
trifluoroacetic acid
acetonitrile
inert atmosphere
Prior art date
Application number
NO901881A
Other languages
English (en)
Norwegian (no)
Other versions
NO901881D0 (no
NO901881L (no
Inventor
Nicholas Alex Saccomano
Robert Alfred Volkmann
Original Assignee
Pfizer
Natural Product Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Natural Product Sciences Inc filed Critical Pfizer
Publication of NO901881D0 publication Critical patent/NO901881D0/no
Publication of NO901881L publication Critical patent/NO901881L/no
Priority to NO19963876A priority Critical patent/NO315372B1/no
Publication of NO300128B1 publication Critical patent/NO300128B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/16—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Insects & Arthropods (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
NO901881A 1989-04-28 1990-04-27 Fremgangsmåte for fremstilling av polyaminer i edderkoppgift NO300128B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO19963876A NO315372B1 (no) 1989-04-28 1996-09-16 Vesentlig ren polyaminforbindelse, anvendelse derav og farmasöytiske sammensetninger

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34618189A 1989-04-28 1989-04-28

Publications (3)

Publication Number Publication Date
NO901881D0 NO901881D0 (no) 1990-04-27
NO901881L NO901881L (no) 1990-10-29
NO300128B1 true NO300128B1 (no) 1997-04-14

Family

ID=23358305

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901881A NO300128B1 (no) 1989-04-28 1990-04-27 Fremgangsmåte for fremstilling av polyaminer i edderkoppgift

Country Status (25)

Country Link
EP (2) EP0696578A3 (cs)
JP (8) JPH0774187B2 (cs)
KR (2) KR920007554B1 (cs)
CN (2) CN1038931C (cs)
AT (1) ATE131813T1 (cs)
AU (1) AU615144B2 (cs)
CA (2) CA2015505C (cs)
CZ (1) CZ283830B6 (cs)
DD (2) DD298412A5 (cs)
DE (1) DE69024253T2 (cs)
DK (1) DK0395357T3 (cs)
EG (1) EG19311A (cs)
ES (1) ES2081929T3 (cs)
FI (1) FI902139A7 (cs)
GR (1) GR3018976T3 (cs)
HU (1) HU223593B1 (cs)
IE (2) IE950345L (cs)
IL (3) IL94147A (cs)
NO (1) NO300128B1 (cs)
NZ (2) NZ244480A (cs)
PL (1) PL165148B1 (cs)
PT (1) PT93876B (cs)
RU (1) RU2037498C1 (cs)
YU (1) YU84590A (cs)
ZA (1) ZA903229B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122596A (en) * 1989-09-29 1992-06-16 Pfizer Inc. Polypeptides useful as blockers of calcium channels
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters
US5312928A (en) * 1991-02-11 1994-05-17 Cambridge Neuroscience Calcium channel antagonists and methodology for their identification
US5461032A (en) * 1991-03-01 1995-10-24 Fmc Corporation Insecticidally effective peptides
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5185369A (en) * 1991-08-23 1993-02-09 Pfizer Inc. Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
DE69233586T2 (de) * 1991-08-23 2006-09-28 NPS Pharmaceuticals, Inc., Salt Lake City Kalzium-Rezeptor aktive Verbindungen
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
IL104419A0 (en) * 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5763568A (en) * 1992-01-31 1998-06-09 Zeneca Limited Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
JP4143118B2 (ja) * 1993-02-23 2008-09-03 ブリガム・アンド・ウイミンズ・ホスピタル・インコーポレイテッド カルシウム受容体活性化分子およびその関連物
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
WO1995013818A1 (en) * 1993-11-15 1995-05-26 Baker Medical Research Institute A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
CA2202879C (en) 1994-10-21 2005-08-30 Bradford C. Van Wagenen Calcium receptor-active compounds
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
US5756459A (en) * 1995-06-07 1998-05-26 Fmc Corporation Insecticidally effective peptides isolatable from phidippus spider venom
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
JP4117506B2 (ja) 1996-05-01 2008-07-16 エヌピーエス ファーマシューティカルズ インコーポレイテッド 無機イオン活性化合物
AUPO733397A0 (en) * 1997-06-13 1997-07-10 University Of Sydney, The Pesticidal compounds
CN1071115C (zh) * 1998-08-07 2001-09-19 彭小平 一种治疗胃肠炎及溃疡的复方药
FR2802817B1 (fr) * 1999-12-23 2002-10-11 Centre Nat Rech Scient Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete
WO2001070773A2 (en) * 2000-03-22 2001-09-27 Basf Ag Insecticidal peptides and methods for using same
FR2820136A1 (fr) * 2001-01-26 2002-08-02 Aventis Pharma Sa Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
FR2885129B1 (fr) 2005-04-29 2007-06-15 Proskelia Sas Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation.
CN108949771B (zh) * 2018-08-02 2021-10-19 南京农业大学 拟环纹豹蛛c家族杀虫基因及其编码的成熟肽与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
GB8820442D0 (en) * 1988-08-30 1988-09-28 Usherwood P N R Therapeutic polyamine amides

Also Published As

Publication number Publication date
CN1038931C (zh) 1998-07-01
JP2747279B2 (ja) 1998-05-06
CZ283830B6 (cs) 1998-06-17
JPH0774187B2 (ja) 1995-08-09
EP0395357B1 (en) 1995-12-20
CS215790A3 (en) 1992-02-19
JP2746359B2 (ja) 1998-05-06
NO901881D0 (no) 1990-04-27
KR900015745A (ko) 1990-11-10
JP2746361B2 (ja) 1998-05-06
IL94147A (en) 1998-10-30
PT93876A (pt) 1990-11-20
DE69024253T2 (de) 1996-05-15
JPH09118694A (ja) 1997-05-06
JP2744904B2 (ja) 1998-04-28
JPH09118691A (ja) 1997-05-06
FI902139A7 (fi) 1990-10-29
AU615144B2 (en) 1991-09-19
NZ244480A (cs) 1994-12-22
KR930000163B1 (ko) 1993-01-11
HU902610D0 (en) 1990-09-28
JPH09132596A (ja) 1997-05-20
DD298412A5 (de) 1992-02-20
JPH07165793A (ja) 1995-06-27
CA2015505A1 (en) 1990-10-28
IE69848B1 (en) 1996-10-02
EG19311A (en) 1995-02-28
JPH09118693A (ja) 1997-05-06
EP0395357A3 (en) 1992-04-01
FI902139A0 (fi) 1990-04-27
DD293959A5 (de) 1991-09-19
DE69024253D1 (de) 1996-02-01
EP0395357A2 (en) 1990-10-31
ES2081929T3 (es) 1996-03-16
CA2194103C (en) 2000-01-04
EP0696578A2 (en) 1996-02-14
KR920007554B1 (ko) 1992-09-07
CN1047078A (zh) 1990-11-21
ZA903229B (en) 1991-12-24
IE901496L (en) 1990-10-28
EP0696578A3 (en) 1998-04-29
JPH09118690A (ja) 1997-05-06
GR3018976T3 (en) 1996-05-31
HUT55415A (en) 1991-05-28
JPH0314551A (ja) 1991-01-23
CA2194103A1 (en) 1990-10-29
IL112522A0 (en) 1995-05-26
IE950345L (en) 1990-10-28
PT93876B (pt) 1996-09-30
DK0395357T3 (da) 1996-01-29
NO901881L (no) 1990-10-29
ATE131813T1 (de) 1996-01-15
AU5453590A (en) 1990-11-08
YU84590A (sh) 1992-09-07
HU223593B1 (hu) 2004-09-28
NZ233469A (cs) 1994-12-22
RU2037498C1 (ru) 1995-06-19
PL165148B1 (en) 1994-11-30
IL94147A0 (en) 1991-01-31
IL112522A (en) 2005-12-18
JP2691141B2 (ja) 1997-12-17
JP2746360B2 (ja) 1998-05-06
JPH09118692A (ja) 1997-05-06
CA2015505C (en) 1997-03-11
CN1136960A (zh) 1996-12-04

Similar Documents

Publication Publication Date Title
NO300128B1 (no) Fremgangsmåte for fremstilling av polyaminer i edderkoppgift
US5037846A (en) Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters
US4668797A (en) Bicyclic aminoacids as intermediates and processes for their preparation
JP2625523B2 (ja) ジペプチド類
NO165148B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av tricykliske aminosyrer.
US5587505A (en) Triterpene derivatives and endothelin-receptor antagonists containing the same
US5227397A (en) Polyamines and polypeptides useful as antagonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels
CN114478522B (zh) 一种吡啶并咪唑类衍生物及其制备方法与应用
NO175208B (cs)
DE3506307C2 (cs)
NO315372B1 (no) Vesentlig ren polyaminforbindelse, anvendelse derav og farmasöytiske sammensetninger
EP0991650B1 (fr) Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
FI102171B (fi) Menetelmä terapeuttisesti käyttökelpoisen olennaisen puhtaan polyamiin in ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
CZ282990B6 (cs) Čištěná polypeptidová sloučenina, postup její přípravy a farmaceutický prostředek obsahující tuto sloučeninu
CA1199032A (en) Derivatives of n-(4-phenylcyclohexy)glycines
CA1197252A (en) Derivatives of cis, endo-2-azabicyclo-[3.3.0]- octane-3-carboxylic acid a process for their preparation, agents containing these compounds and their use
IE893103A1 (en) "A process for the preparation of a 1,4-dihydropyridine derivative, namely (-)-2-{[2-(2-aminoethoxy)ethoxy] methyl}-4-(2,3-dichlorophenyl)-3-ethoxy-carbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine, and its salts"
CN1972910A (zh) 内酰胺速激肽受体拮抗剂
CN115417789A (zh) 一种治疗帕金森氏病的新化合物、其制备方法以及复方药物组合物和应用

Legal Events

Date Code Title Description
MK1K Patent expired